139 related articles for article (PubMed ID: 35516906)
1. Synthesis and biological evaluation of 4-(1
Abuelizz HA; Awad HM; Marzouk M; Nasr FA; Alqahtani AS; Bakheit AH; Naglah AM; Al-Salahi R
RSC Adv; 2019 Jun; 9(33):19065-19074. PubMed ID: 35516906
[TBL] [Abstract][Full Text] [Related]
2. Exploiting the 4-hydrazinobenzoic acid moiety for the development of anticancer agents: Synthesis and biological profile.
Abuelizz HA; Awad HM; Marzouk M; Nasr FA; Bakheit AH; Naglah AM; Al-Shakliah NS; Al-Salahi R
Bioorg Chem; 2020 Sep; 102():104098. PubMed ID: 32702510
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells.
Alam MM; Malebari AM; Syed N; Neamatallah T; Almalki ASA; Elhenawy AA; Obaid RJ; Alsharif MA
Bioorg Med Chem; 2021 May; 38():116136. PubMed ID: 33894490
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel (Z)-5-((1,3-diphenyl-1H-pyrazol-4-yl)methylene)-3-((1-substituted phenyl-1H-1,2,3-triazol-4-yl)methyl)thiazolidine-2,4-diones: a potential cytotoxic scaffolds and their molecular modeling studies.
Subhashini NJP; Kumar KP; Kumar EP; Shravani P; Singh SS; Vani T; Vijjulatha M
Mol Divers; 2021 Nov; 25(4):2017-2033. PubMed ID: 32361888
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
[TBL] [Abstract][Full Text] [Related]
7. Novel triazolophthalazine-hydrazone hybrids as potential PCAF inhibitors: Design, synthesis, in vitro anticancer evaluation, apoptosis, and molecular docking studies.
Abulkhair HS; Turky A; Ghiaty A; Ahmed HEA; Bayoumi AH
Bioorg Chem; 2020 Jul; 100():103899. PubMed ID: 32454390
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of ciprofloxacin - 1,2,3-triazole hybrids as antitumor, antibacterial, and antioxidant agents.
Al-Taweel S; Al-Saraireh Y; Al-Trawneh S; Alshahateet S; Al-Tarawneh R; Ayed N; Alkhojah M; Al-Khaboori W; Zereini W; Al-Qaralleh O
Heliyon; 2023 Dec; 9(12):e22592. PubMed ID: 38125538
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids.
Liu HJ; Huang X; Shen QK; Deng H; Li Z; Quan ZS
Iran J Pharm Res; 2021; 20(2):144-155. PubMed ID: 34567152
[TBL] [Abstract][Full Text] [Related]
10. Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability.
Ihmaid SK; Alraqa SY; Aouad MR; Aljuhani A; Elbadawy HM; Salama SA; Rezki N; Ahmed HEA
Bioorg Chem; 2021 Jun; 111():104835. PubMed ID: 33798850
[TBL] [Abstract][Full Text] [Related]
11. Discovery of new quinoxaline-2(1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation.
El-Adl K; Sakr HM; Yousef RG; Mehany ABM; Metwaly AM; Elhendawy MA; Radwan MM; ElSohly MA; Abulkhair HS; Eissa IH
Bioorg Chem; 2021 Sep; 114():105105. PubMed ID: 34175720
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of pyrazolo-triazole hybrids as cytotoxic and apoptosis inducing agents.
Srinivasa Reddy T; Kulhari H; Ganga Reddy V; Subba Rao AV; Bansal V; Kamal A; Shukla R
Org Biomol Chem; 2015 Oct; 13(40):10136-49. PubMed ID: 26346902
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Biological Evaluation of 1,2,3-Triazole Tethered Thymol-1,3,4-Oxadiazole Derivatives as Anticancer and Antimicrobial Agents.
Almalki ASA; Nazreen S; Malebari AM; Ali NM; Elhenawy AA; Alghamdi AAA; Ahmad A; Alfaifi SYM; Alsharif MA; Alam MM
Pharmaceuticals (Basel); 2021 Aug; 14(9):. PubMed ID: 34577567
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Antiproliferative Evaluation of Novel Hybrids of Dehydroabietic Acid Bearing 1,2,3-Triazole Moiety.
Li FY; Huang L; Li Q; Wang X; Ma XL; Jiang CN; Zhou XQ; Duan WG; Lei FH
Molecules; 2019 Nov; 24(22):. PubMed ID: 31752282
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
16. 3-(1,2,3-Triazol-4-yl)-β-Carbolines and 3-(1
Ribeiro JLP; Loureiro JB; Lopes SMM; Saraiva L; Pinho E Melo TMVD
Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36558961
[TBL] [Abstract][Full Text] [Related]
17. Naproxen Based 1,3,4-Oxadiazole Derivatives as EGFR Inhibitors: Design, Synthesis, Anticancer, and Computational Studies.
Alam MM; Nazreen S; Almalki ASA; Elhenawy AA; Alsenani NI; Elbehairi SEI; Malebari AM; Alfaifi MY; Alsharif MA; Alfaifi SYM
Pharmaceuticals (Basel); 2021 Aug; 14(9):. PubMed ID: 34577570
[TBL] [Abstract][Full Text] [Related]
18. The In Vitro Anticancer Activity and Potential Mechanism of Action of 1-[(1R,2S)-2-fluorocyclopropyl]Ciprofloxacin-(4-methyl/phenyl/benzyl-3- aryl)-1,2,4-triazole-5(4H)-thione Hybrids.
Zhang YZ; Liu HL; He QS; Xu Z
Curr Top Med Chem; 2020; 20(16):1493-1498. PubMed ID: 32156237
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.
El-Adl K; El-Helby AA; Sakr H; Elwan A
Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414
[TBL] [Abstract][Full Text] [Related]
20. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
